MP
PPH icon

McDonald Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

McDonald Partners’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Buy
+325
New +$33.6K 0.01% 346

Other funds holding PPH

AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
RBC
Rye Brook Capital Greenwich, Connecticut $143M AUM 33.65% 1-Year Est. Return
WWM
WT Wealth Management Scottsdale, Arizona $361M AUM 23.03% 1-Year Est. Return
FF
Fluent Financial Dallas, Texas $280M AUM 16.1% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
CWRP
Cassady Wealth & Retirement Planning Henderson, Nevada $215M AUM
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $807M AUM 19.58% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return
WF
Warner Financial Bethesda, Maryland $340M AUM 22.81% 1-Year Est. Return

McDonald Partners's PPH Position: Q2 2026 in Review

McDonald Partners opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 325 shares worth $35.5K. The stake represents 0.01% of the portfolio and ranks #346 among its holdings.

39 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • McDonald Partners held 325 shares of VanEck Pharmaceutical ETF worth $35.5K as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new McDonald Partners position in Q2 2026.
  • VanEck Pharmaceutical ETF made up 0.01% of McDonald Partners's portfolio in Q2 2026, its #346 holding.
  • 39 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.